Edwards Lifesciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Edwards Lifesciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 15% to $6,004,800,000. Profit margin reached 23%. Total operating expenses were $3,090,900,000.

Profit Margin

Edwards Lifesciences Corporation (SIX:EW.SW): Profit margin
2013 2.04B 391.7M 19.15%
2014 2.32B 811.1M 34.92%
2015 2.49B 494.9M 19.85%
2016 2.96B 569.5M 19.22%
2017 3.43B 622.1M 18.11%
2018 3.72B 722.2M 19.4%
2019 4.34B 1.04B 24.08%
2020 4.38B 823.4M 18.77%
2021 5.23B 1.50B 28.73%
2023 6.00B 1.40B 23.35%

EW.SW Income Statement (2013 – 2023)

2023 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
6.00B5.23B4.38B4.34B3.72B3.43B2.96B2.49B2.32B2.04B
Cost of revenue
1.37B1.24B1.08B1.11B939.4M875.3M797.4M617.2M625.6M522.4M
Gross profit
4.62B3.98B3.30B3.23B2.78B2.56B2.16B1.87B1.69B1.52B
Operating exp.
Research and development
1.07B903.1M760.7M752.7M622.2M552.6M477.8M383.1M346.5M323M
Selling and marketing
1.2M000000000
Total operating expenses
3.09B2.39B1.98B1.99B1.71B1.53B1.38B1.23B1.20B1.06B
Operating income
1.53B1.72B1.62B1.23B1.07B1.02B783.8M642.7M482.6M454.5M
Other income (expenses), net
64M-18.4M19.1M-72.2M-311.3M12.2M-45.9M-20.5M661.4M60.8M
Income before tax
1.59B1.70B916.7M1.16B761.4M1.03B737.9M622.4M1.14B515.3M
Income tax expense
198.7M198.9M93.3M119.6M39.2M412.8M168.4M127.5M332.9M123.6M
Net income
1.40B1.50B823.4M1.04B722.2M622.1M569.5M494.9M811.1M391.7M
Earnings per share
Basic EPS
2.302.411.310.550.380.970.30.761.260.19
Diluted EPS
2.292.411.290.550.380.950.290.741.240.19
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source